Back
BioCryst Pharmaceuticals Stock Predictions
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35
BCRX
BioCryst Pharmaceuticals
Last Price:
8.12
Seasonality Move:
-4.61%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.BioCryst Pharmaceuticals Stock Forecast
- Over the next 52 weeks, BioCryst Pharmaceuticals has on average historically risen by 44.4% based on the past 30 years of stock performance.
- BioCryst Pharmaceuticals has risen higher in 18 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is BioCryst Pharmaceuticals Stock Undervalued?
The current BioCryst Pharmaceuticals [BCRX] share price is $8.11. The Score for BCRX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal. - BCRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will BioCryst Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, BioCryst Pharmaceuticals has on average historically risen by 44.4% based on the past 30 years of stock performance.
BioCryst Pharmaceuticals Stock Rating
Sell
35
BioCryst Pharmaceuticals (BCRX)
is a Sell
Is BioCryst Pharmaceuticals overpriced?
- BioCryst Pharmaceuticals has risen higher in 18 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
BioCryst Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biocryst.com
52-Week Data
52-Week High:
8.88
52-Week Low:
4.03
Prediction Charts
Market Cap:
1.68B
Price in USD:
8.11
Volume:
2.17M
Beta:
1.70
Technical Analysis
SMA50:
7.76
SMA100:
6.92
SMA200:
6.19
52-Wk Change:
14.06%
Stock Predictions
-
Is BioCryst Pharmaceuticals stock public?
Yes, BioCryst Pharmaceuticals is a publicly traded company. -
What is the BioCryst Pharmaceuticals stock quote today?
The BioCryst Pharmaceuticals stock price is 8.11 USD today. -
How to buy BioCryst Pharmaceuticals stock online?
You can buy BioCryst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Sep-3 | 8.61 | 8.25 | 8.88 | 8.24 |
| Sep-4 | 8.21 | 8.28 | 8.34 | 8.01 |
| Sep-5 | 8.31 | 8.15 | 8.31 | 8.00 |
| Sep-6 | 8.15 | 7.98 | 8.25 | 7.91 |
| Sep-9 | 8.00 | 7.66 | 8.01 | 7.63 |
| Sep-10 | 7.67 | 7.72 | 7.91 | 7.55 |
| Sep-11 | 7.68 | 7.73 | 7.77 | 7.55 |
| Sep-12 | 7.76 | 7.75 | 7.80 | 7.57 |
| Sep-13 | 7.86 | 7.92 | 7.97 | 7.82 |
| Sep-16 | 7.95 | 7.91 | 8.05 | 7.79 |
| Sep-17 | 7.99 | 7.92 | 8.01 | 7.89 |
| Sep-18 | 7.94 | 7.97 | 8.25 | 7.91 |
| Sep-19 | 8.17 | 8.16 | 8.30 | 8.00 |
| Sep-20 | 8.15 | 8.11 | 8.19 | 7.97 |
BioCryst Pharmaceuticals Earnings
BioCryst Pharmaceuticals Earnings Report: Per Share BioCryst Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
BioCryst Pharmaceuticals Forecast Revenue Growth
BioCryst Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for BioCryst Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.23 per share.
* BioCryst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.